VMP 39733411000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Proguanil 25mg / Atovaquone 62.5mg tablets
BNF code 0504010U0AAABAB
Virtual Therapeutic Moiety Proguanil + Atovaquone
Date identifier became valid 27 May 2021
Previous product identifier 377213008
Basis of preferred name Other
Date of name applicability 27 Apr 2010
Previous name Atovaquone 62.5mg / Proguanil 25mg tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Atovaquone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 62.500
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Proguanil hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Malarone Paediatric 62.5mg/25mg tablets (GlaxoSmithKline UK Ltd)
Virtual Medicinal Product Packs
Proguanil 25mg / Atovaquone 62.5mg tablets 12 tablet

dm+d data retrieved from TRUD: release NHSBSA_9.3.0_20220926000001, imported on 26th September 2022 at 04:57:40.